APLAUD
Conclusion The high-dose arm was ended early due to cases of excessive bleeding; the phase III study (BRAVO) was terminated in December 2000 due to lack of efficacy and safety concerns
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.